Maxair and Insulin resistance - a phase IV clinical study of FDA data

Summary:

Insulin resistance is reported only by a few people who take Maxair.

The phase IV clinical study analyzes which people take Maxair and have Insulin resistance. It is created by eHealthMe based on reports of 2,870 people who have side effects while taking Maxair from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Nov, 26, 2022

2,870 people reported to have side effects when taking Maxair.
Among them, 3 people (0.1%) have Insulin resistance.


What is Maxair?

Maxair has active ingredients of pirbuterol acetate. It is often used in asthma. eHealthMe is studying from 2,901 Maxair users for its effectiveness, alternative drugs and more.

What is Insulin resistance?

Insulin resistance is found to be associated with 748 drugs and 359 conditions by eHealthMe.

Number of Maxair and Insulin resistance reports submitted per year:

Could Maxair cause Insulin resistance?

Gender of people who have Insulin resistance when taking Maxair *:

  • female: 33.33 %
  • male: 66.67 %

Age of people who have Insulin resistance when taking Maxair *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 66.67 %
  • 20-29: 0.0 %
  • 30-39: 33.33 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 0.0 %

Common drugs people take besides Maxair *:

  1. Vanceril: 3 people, 100.00%
  2. Nutropin Aq: 2 people, 66.67%
  3. Humulin R: 2 people, 66.67%
  4. Theo-Dur: 2 people, 66.67%
  5. Accolate: 2 people, 66.67%
  6. Rhinocort: 1 person, 33.33%
  7. Prednisone: 1 person, 33.33%
  8. Serevent: 1 person, 33.33%
  9. Singulair: 1 person, 33.33%
  10. Soma: 1 person, 33.33%

Common side effects people have besides Insulin resistance *:

  1. Pseudotumor Cerebri (increased pressure within the brain in the absence of a tumour): 2 people, 66.67%
  2. Papilloedema (optic disc swelling): 2 people, 66.67%
  3. Spinal Disorder (disease of spine a back bone): 1 person, 33.33%
  4. Immobile (not moving): 1 person, 33.33%
  5. Adverse Event: 1 person, 33.33%
  6. Bone Disorder: 1 person, 33.33%
  7. Cervical Spinal Stenosis (narrowing of the spinal canal in the neck): 1 person, 33.33%
  8. Corneal Thinning: 1 person, 33.33%
  9. Disability: 1 person, 33.33%
  10. Glaucoma (increased fluid pressure in the eye with vision loss): 1 person, 33.33%

Common conditions people have *:

  1. Growth Hormone Deficiency: 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Maxair and have Insulin resistance?

Check whether Insulin resistance is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

How severe was Insulin resistance and when was it recovered:

Expand to all the drugs that have ingredients of pirbuterol acetate:

Alternative drugs to, pros and cons of Maxair:

Common Maxair side effects:

Browse all side effects of Maxair:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Insulin resistance treatments and more:

COVID vaccines that are related to Insulin resistance:

Common drugs associated with Insulin resistance:

All the drugs that are associated with Insulin resistance:

Common conditions associated with Insulin resistance:

All the conditions that are associated with Insulin resistance:

How the study uses the data?

The study uses data from the FDA. It is based on pirbuterol acetate (the active ingredients of Maxair) and Maxair (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: